Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bristol-Myers Squibb And The Promise Of Cancer Immunotherapy
Seeking Alpha
Tuesday, September 25, 2012 - 11:53am
tags:
Bristol-Myers Squibb, melanoma, Yervoy
Celgene CVR: Upside Into Abraxane Pancreatic Cancer Trial Data
TheStreet.com
Tuesday, September 25, 2012 - 11:37am
tags:
Celgene, Abraxane, pancreatic cancer
Biomarin: Four Clinical Trial Events to Watch Before Year End
TheStreet.com
Tuesday, September 25, 2012 - 11:27am
tags:
Biomarin, BMN-111, GALNs, BMRN-763, Peg-Pal
Cosmo Pharma CEO Sees $1.5 Billion Dye Luring Buyer by 2013
Bloomberg
Tuesday, September 25, 2012 - 11:15am
tags:
Cosmo Pharma, M&A
New CEO at GenVec slashes jobs but shelters Novartis partnership
Fierce Biotech
Tuesday, September 25, 2012 - 11:06am
tags:
GenVec, layoffs, Novartis
1 Pharma That's Failing Forward
Motley Fool
Tuesday, September 25, 2012 - 11:03am
tags:
Astex, amuvatinib, Dacogen
Scientists Rank Genzyme Among Best Employers
Yahoo
Tuesday, September 25, 2012 - 11:02am
tags:
Genzyme
How Many Pharmas Does It Take to Accelerate Drug Development?
Motley Fool
Tuesday, September 25, 2012 - 10:04am
tags:
drug development, Abbott Labs, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, GSK, JNJ, Pfizer, Roche, Sanofi, TransCelerate BioPharma
2 Drug Approvals and Shares Drop? That's Biotech!
Motley Fool
Tuesday, September 25, 2012 - 9:46am
tags:
Regeneron, Eylea, macular edema, age-related macular degeneration
PTIE's Remoxy Remains High On Pfizer's List of Key Drug Candidates
Yahoo/Reuters
Tuesday, September 25, 2012 - 9:44am
tags:
Remoxy, Pfizer, Pain Therapeutics
Sanofi to cut 900 jobs in France by 2015, Reuters reports
Yahoo/Fly the on Wall
Tuesday, September 25, 2012 - 9:42am
tags:
Sanofi, layoffs, France
In The Wake Of An FDA Probe, It's Time Questcor Shareholders Begin To Consider Alternatives
Seeking Alpha
Monday, September 24, 2012 - 6:03pm
tags:
FDA, Questcor, Arena Pharmaceuticals, Merck, Pfizer, Vivus, Athcar
With Arena, Patience Is A Virtue
Seeking Alpha
Monday, September 24, 2012 - 5:59pm
tags:
Arena Pharmaceuticals, Belviq, obesity
Diovan Generic Launched by Mylan
Yahoo/Zacks
Monday, September 24, 2012 - 5:57pm
tags:
Mylan, Diovan, generics, Novartis, antihypertensives
Will Abbott's Magic Pill Send Stock Soaring?
Seeking Alpha
Monday, September 24, 2012 - 5:56pm
tags:
Abbott Labs, testosterone, Androgel
Drug-Trial Operator Quintiles Said to Study Initial Offering
Bloomberg
Monday, September 24, 2012 - 12:16pm
tags:
Quintiles, IPO
Pfizer: Here’s How We are Combating Generic Drugs
Wall St. Cheat Sheet
Monday, September 24, 2012 - 12:14pm
tags:
generics, Pfizer, Eliquis, Bristol-Myers Squibb
Valeant buys Visudyne drug from QLT; QLT stock jumps
Reuters
Monday, September 24, 2012 - 11:20am
tags:
Valeant Pharmaceuticals, Visudyne, QLT, age-related macular degeneration
3 Pharmaceuticals Pursuing Non-Surgical Approaches To Combating Cancer
Seeking Alpha
Monday, September 24, 2012 - 11:18am
tags:
OncoSec, Celsion, AngioDynamics, Bristol-Myers Squibb, cancer
The Promising, Cheap, And Growing Cell Therapy Arena Continues To Outperform The Market
Seeking Alpha
Monday, September 24, 2012 - 11:17am
tags:
Neuralstem, NeoStem, Osiris, Pluristem, stem cells, StemCells

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.